¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive hypertrophic interstitial neuritis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive mean
    ´©°¡Æò±Õ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é(»ö)Áú³úº´(Áõ)
  • progressive muscular dystrophy
    ÁøÇà±Ù(À°)µð½ºÆ®·ÎÇÇ
  • progressive myopia
    ÁøÇà±Ù½Ã
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • progressive outer retinal necrosis
    ÁøÇ༺¿Ü¸Á¸·±«»ç
  • progressive pigmentary dermatosis
    ÁøÇà»ö¼ÒÇǺκ´
  • progressive resistance
    Á¡ÁõÀúÇ×
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿
  • progressive spastic spinal paralysis
    ÁøÇà°­Á÷ô¼ö¸¶ºñ
  • progressive spinal amyotrophy
    ÁøÇàô¼ö±Ù(À°)À§Ãà(Áõ)
  • progressive spinal muscular atrophy
    ÁøÇàô¼ö¼º±Ù(À°)À§ÃàÁõ
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´(Áõ), ÁøÇàÇÇÁúÇϳúº´(Áõ)
  • progressive supranuclear palsy
    ÁøÇàÇٻ󸶺ñ
  • progressive systemic sclerosis
    ÁøÇàÀü½Å°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • interstitial lamella
    »çÀÌÃþÆÇ
  • interstitial mastitis
    °£ÁúÀ¯¹æ¿°, »çÀÌÁúÀ¯¹æ¿°
  • interstitial nephritis
    »çÀÌÁúÄáÆÏ¿°
  • interstitial nucleus
    »çÀÌÁúÇÙ
  • interstitial opacity
    »çÀÌÁúȥŹ
  • interstitial pancreatitis
    °£ÁúÀÌÀÚ¿°
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • interstitial pregnancy
    Àڱú®ÀڱðüÀÓ½Å, »çÀÌÁúÀÓ½Å
  • interstitial salpingitis
    »çÀÌÁúÀڱðü¿°
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • interstitial fluid pressure
    °£Áú¾×¾Ð·Â
  • luetic interstitial keratitis
    ¸Åµ¶»çÀÌÁú°¢¸·¿°
  • acquired progressive lymphangioma
    ÈÄõÁøÇาÇÁ°üÁ¾
  • idiopathic progressive atrophoderma
    ¿øÀκҸíÁøÇàÇǺÎÀ§ÃàÁõ
  • neural progressive muscular atrophy
    ½Å°æÁøÇà±ÙÀ°À§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hypertrophic subaortic stenosis
    ºñÈļº(ºñ´ë¼º)´ëµ¿¸ÆÇÏ ÇùÂø.(¡­ÓÞÔÑØæù» úõó¸)
  • hypertrophic subaortic stenosis,idiopathic
    Ư¹ß¼º
  • hypertrophic type
    ºñ´ëÇü
  • hypertrophic vulvitis
    ºñ´ë¼º ¿ÜÀ½¿°(¡­èâëäæú).
  • hypertrophic zone
    ºñ´ëÃþ
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º °úÇü¼º °ñ°üÀýº´Áõ.
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º °ñ ´Ù°øÁõ(÷åÛ¡àõÍéÒýÍîñø), Ư¹ß¼º °ñ Á¶¼ÛÁõ(÷åÛ¡àõÍéðØáçñø), Ư¹ß¼º °úÇü¼º °ñ°üÀýº´Áõ.
  • idiopathic hypertrophic subaortic stenosis
    Ư¹ß¼º ºñÈļº ´ëµ¿¸ÆÆÇ ÇϺÎÇùÂø(Áõ).
  • idiopathic hypertrophic subaortic stenosis
    Ư¹ß¼ººñÈļº´ëµ¿¸ÆÆÇÇϺÎÇùÂø(¡­Ýþý§àõÓÞÔÑØæ÷ùù»Ý»úõó¸)
  • pharyngitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º) Àεο°
  • pulmonary hypertrophic osteopathy
    Æó¼º ºñ´ë¼º °ñº´Áõ.
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º °ñº´Áõ(øËàõÝþÓÞàõ ÍéÜ»ñø)
  • acquired progressive lymphangioma
    ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
  • hereditary progressive mucinous histiocytosis X
    À¯Àü¼º ÁøÇ༺ Á¡¾×¼ºÁ¶Á÷±¸Áõ
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º °ñº´Áõ(øËàõÝþÓÞàõ ÍéÜ»ñø)
  • rhinitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º)ºñ¿°
  • rhinitis, hypertrophic
    ºñÈÄ(¼º) ºñ¿°
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ°üÀýº´Áõ(¡­ÝþÓÞàõ Íéμï½Ü»ñø).
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ°üÀýº´Áõ(¡­ÝþÓÞàõ Íéμï½Ü»ñø)
  • adventitial neuritis
    ¿ÜÃʽŰ濰(èâõ¦ãêÌèæú).
  • alcoholic neuritis
    ¾ËÄÚ¿Ã(¼º) ½Å°æ¿°(¡­ãêÌèæú).
  • arsenical neuritis
    ºñ¼Ò(¼º) ½Å°æ¿° (¡­ãêÌèæú).
  • ascending neuritis
    »óÇ༺ ½Å°æ¿°.
  • axial neuritis
    Ã༺½Å°æ¿°.
  • axial optic neuritis
    Ã༺½Ã½Å°æ¿°.
  • axial retrobulbar neuritis
    Ã༺±¸ÈĽýŰ濰
  • brachial neuritis
    »ó¿Ï½Å°æ¿°.
  • brachial neuritis
    »ó¿Ï ½Å°æ¿°.
  • compression neuritis
    ¾Ð¹Ú ½Å°æ¿°(¡­ãêÌèæú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BHR basal heart rate; benign hypertrophic prostatitis; bronchial hyperreactivity
CMH cardiomyopathy, hypertrophic; community mental health [services or program]; congenital malformation...
HC hair cell; hairy cell; handicapped; head circumference; head compression; health care; healthy contr...
HCM health care management; hypertrophic cardiomyopathy
HHCS high-altitude hypertrophic cardiomyopathy syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CPEO Chronic Progressive External Ophthalmoplegia
OPP Ovine progressive pneumonia
PPA Primary Progressive Aphasia
PAL progressive addition lens
PD Progressive Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • progressive muscular dystrophy
    ÁøÇ༺ ±Ù ÀÌ¿µ¾çÁõ
  • progressive myopia
    ÁøÇ༺ ±Ù½Ã
  • progressive paralysis
    ÁøÇ༺ ¸¶ºñ
    ¸Åµ¶¿¡ °¨¿°µÈ ÈÄ 3¡­40³â
  • progressive patient care
    ´Ü°èÀû ȯÀÚ °ü¸®
  • progressive relaxation tape
    Á¡ÁøÀû ÀÌ¿Ï Å×ÀÌÇÁ
  • progressive resistance
    Á¡Áõ ÀúÇ×
  • progressive scleroderma
    ÁøÇ༺ °øÇÇÁõ
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±Ù À§ÃàÁõ
  • progressive supranuclear palsy
    ÁøÇ༺ ÇÙ»ó ¸¶ºñ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °øÇÇÁõ
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • symmetrical progressive erythrokeratoderma
    ´ëμº ÁøÇ༺ È«¹Ý °¢ÇÇÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
traumatic neuritis Nerve lesion following an injury.
(05 Mar 2000)
fallopian neuritis Paralysis of the facial muscles, usually unilateral, due to either a lesion involving the nucleus or the facial nerve peripheral to the nucleus (peripheral facial paralysis) or a supranuclear lesion in the cerebrum or upper brainstem (central facial paralysis). With latter, facial weakness is usually partial and the upper portion of the face is relatively spared, due to bilateral cortical connections.
(12 Dec 1998)
Leyden's neuritis Fatty degeneration of the fibres of the affected nerve.
(05 Mar 2000)
aphasia, primary progressive A type of aphasia appearing gradually and gradually worsening without any major change in other cognitive functions. It is regarded by some authors as a syndrome which may be due to various degenerative diseases of the cerebral cortex (notably alzheimer disease, owing to its frequency), while others see in it an autonomous disease related to a neuropathological process that is distinct from the main degenerative dementias. The principal clinical peculiarity of primary progressive aphasia is that it spares the patient's autonomy for a long time, but ultimately turns into global dementia.
(12 Dec 1998)
bovine progressive degenerative myeloencephalopathy A familiar myeloencephalopathy of brown Swiss cattle characterised by bilateral hindleg weakness and ataxia and deficient proprioceptive reflexes.
(05 Mar 2000)
rapidly progressive glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
chronic progressive chorea A progressive disorder usually beginning in young to middle age, consisting of a triad of choreoathetosis, dementia, and autosomal dominant inheritance with complete penetrance. Bilateral marked wasting of the putamen and the head of the caudate nucleus is characteristic.
Synonym: chronic progressive chorea, degenerative chorea, hereditary chorea, Huntington's disease.
(05 Mar 2000)
chronic progressive external ophthalmoplegia A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
chronic progressive syphilitic meningoencephalitis Syphilitic infection manifested as dementia (often with delusional features), dysarthria, seizures, myoclonic jerks, action tremor, impaired walking and standing, pupillary abnormalities, and abnormal CSF findings.
Synonym: chronic progressive syphilitic meningoencephalitis.
(05 Mar 2000)
primary progressive cerebellar degeneration A familial ataxic condition related to cerebellar degeneration.
(05 Mar 2000)
progressive Advancing, going forward, going from bad to worse, increasing in scope or severity.
(18 Nov 1997)
progressive bacterial synergistic gangrene Undermining ulcer of the skin and subcutaneous tissues, usually following an operation, caused by a synergistic interaction between microaerophilic nonhemolytic streptococci and aerobic haemolytic staphylococci.
Synonym: Meleney's gangrene, progressive bacterial synergistic gangrene.
(05 Mar 2000)
progressive bulbar palsy One of the subgroups of motor neuron disease; a progressive degenerative disorder of the motor neurons of primarily the brainstem, manifested as weakness (and wasting) of the various bulbar muscles, resulting in dysarthria and dysphagia-fluid regurgitation is an outstanding symptom and can cause aspiration; tongue weakness and wasting is usually evident, and often the fasciculation potentials are present in the tongue and facial muscles.
Synonym: glossopalatolabial paralysis, glossopharyngeolabial paralysis.
(05 Mar 2000)
progressive bulbar paralysis Progressive weakness and atrophy of the muscles of the tongue, lips, palate, pharynx, and larynx, usually occurring in later life; most often caused by motor neuron disease.
Synonym: bulbar palsy, bulbar paralysis, Duchenne's disease, Erb disease, glossolabiolaryngeal paralysis, glossolabiopharyngeal paralysis.
(05 Mar 2000)
progressive cataract A cataract in which the opacification process progresses to involve the entire lens.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á